236 related articles for article (PubMed ID: 10398815)
1. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
[TBL] [Abstract][Full Text] [Related]
2. Recommended restrictions after 131I therapy: measured doses in family members.
Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
Health Phys; 1999 Feb; 76(2):129-36. PubMed ID: 9929123
[TBL] [Abstract][Full Text] [Related]
3. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
5. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
[TBL] [Abstract][Full Text] [Related]
6. Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism.
Barrington SF; Anderson P; Kettle AG; Gadd R; Thomson WH; Batchelor S; Mountford PJ; Harding LK; O'Doherty MJ
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2097-104. PubMed ID: 18682934
[TBL] [Abstract][Full Text] [Related]
7. Release of patients after therapy with unsealed radionuclides.
International Commission on Radiological Protection
Ann ICRP; 2004; 34(2):v-vi, 1-79. PubMed ID: 15571759
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
9. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance.
Reiners C; Lassmann M
Eur J Nucl Med; 1999 Jul; 26(7):683-5. PubMed ID: 10398814
[No Abstract] [Full Text] [Related]
11. An engagement factor for caregiver radiation dose assessment with radioiodine treatment.
Lee HK; Hong SJ; Jeong KH; Jung JW; Kim SM; Kang YH; Han MS
Radiat Prot Dosimetry; 2015 Mar; 163(4):499-508. PubMed ID: 25028695
[TBL] [Abstract][Full Text] [Related]
12. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131.
Cappelen T; Unhjem JF; Amundsen AL; Kravdal G; Følling I
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):81-6. PubMed ID: 16151768
[TBL] [Abstract][Full Text] [Related]
13. Regulations and policies on radioiodine 131I therapy in Europe.
Beckers C
Thyroid; 1997 Apr; 7(2):221-4. PubMed ID: 9133689
[TBL] [Abstract][Full Text] [Related]
14. Measurement of radiation exposure in relatives of thyroid cancer patients treated with (131)I.
Ramírez-Garzón YT; Ávila O; Medina LA; Gamboa-deBuen I; Rodríguez-Laguna A; Buenfil AE; Ruíz-Trejo C; Estrada E; Brandan ME
Health Phys; 2014 Nov; 107(5):410-6. PubMed ID: 25271931
[TBL] [Abstract][Full Text] [Related]
15. Radiation exposure to family and household members after prostate brachytherapy.
Michalski J; Mutic S; Eichling J; Ahmed SN
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):764-8. PubMed ID: 12788183
[TBL] [Abstract][Full Text] [Related]
16. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
Marriott CJ; Webber CE; Gulenchyn KY
Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
[TBL] [Abstract][Full Text] [Related]
17. A practical guideline for the release of patients treated by I-131 based on Monte Carlo dose calculations for family members.
Han EY; Lee C; Mcguire L; Bolch WE
J Radiol Prot; 2014 Jun; 34(2):N7-17. PubMed ID: 24705486
[TBL] [Abstract][Full Text] [Related]
18. Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.
Al-Mohammed HI; Sulieman A; Mayhoub FH; Salah H; Lagarde C; Alkhorayef M; Aldhebaib A; Kappas C; Bradley DA
Sci Rep; 2021 Jul; 11(1):14557. PubMed ID: 34267237
[TBL] [Abstract][Full Text] [Related]
19. [Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities].
Sapienza MT; Willegaignon J; Ono CR; Watanabe T; Guimarães MI; Gutterres RF; Maréchal MH; Buchpiguel CA
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):318-25. PubMed ID: 19578592
[TBL] [Abstract][Full Text] [Related]
20. Fetal dose estimates and the ICRP abdominal dose limit for occupational exposure of pregnant staff to technetium-99m and iodine-131 patients.
Mountford PJ; Steele HR
Eur J Nucl Med; 1995 Oct; 22(10):1173-9. PubMed ID: 8542902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
